Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerco Regulatory News (SRP)

Share Price Information for Serco (SRP)

Share Price is delayed by 15 minutes
Get Live Data
253.60    -0.20 (-0.08%)
Bid:
254.00
Ask:
254.80
Spread: 0.80 (0.315%)
Market Cap: £2.51b
SRP Live PriceLast checked at - London Stock Exchange

Intraday Serco Share Chart

Share re-purchase

17 Aug 2022 07:00

RNS Number : 2427W
Serco Group PLC
17 August 2022
 

Serco share repurchase programme

 

17 August 2022

 

Serco today provides this further announcement, in connection with its intention as announced on 23 February 2022 to repurchase shares valued at up to £90 million. As announced on 8 March 2022, the first buyback tranche was to repurchase shares with a value of up to £40 million during the period starting on 8 March 2022 and ending no later than 16 August 2022. This first buyback tranche has now completed and during that period the aggregate number of shares purchased was 25,245,738] shares. The second buyback tranche will be a programme with a value of up to £50 million (the "Programme"). This will occur during the period starting 17 August 2022 and ending no later than 31 December 2022 (the "Engagement Period"). The aggregate number of shares acquired by the Company shall not exceed the balance of 106,229,148 shares remaining of the 121,800,878 shares authorised by shareholders at the 2022 Annual General Meeting. It is intended that any shares repurchased under the Programme will be transferred into treasury and subsequently cancelled.

 

The Company has entered into an agreement with Barclays under which it has issued an irrevocable instruction to Barclays to manage the Programme for the Engagement Period. Barclays will carry out the instruction through the acquisition of ordinary shares in the Company for subsequent repurchase by the Company. This arrangement is in accordance with Chapter 12 of the FCA's Listing Rules and the Company's general authority to repurchase shares.

 

In accordance with Article 5(1)(b) of Regulation (EU) No. 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation) detailed information about the individual purchases can be seen below.

 

Ends

 

For further information please contact:

Paul Checketts, Head of Investor Relations, tel: +44 (0) 7718 195 074 or email: paul.checketts@serco.com

Marcus De Ville, Head of Media Relations, tel: +44 (0) 7738 898 550 or email: marcus.deville@serco.com

 

About Serco

Serco is a leading provider of public services. Our customers are governments or others operating in the public sector. We gain scale, expertise and diversification by operating internationally across five sectors and four geographies: Defence, Justice & Immigration, Transport, Health and Citizen Services, delivered in UK & Europe, North America, Asia Pacific and the Middle East. More information can be found at www.serco.com

 

LEI: 549300PT2CIHYN5GWJ21

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSSFFESMEESEFA
Date   Source Headline
30th Jul 20202:21 pmRNSHolding(s) in Company
16th Jul 20203:53 pmRNSDirectorate Change - NED Changes
1st Jul 20202:40 pmRNSTotal Voting Rights
29th Jun 20202:01 pmRNSHolding(s) in Company
26th Jun 202012:55 pmRNSHolding(s) in Company
25th Jun 20203:42 pmRNSHolding(s) in Company
23rd Jun 20203:15 pmRNSDirector/PDMR Shareholding
23rd Jun 20202:50 pmRNSHolding(s) in Company
22nd Jun 20202:31 pmRNSHolding(s) in Company
17th Jun 20204:11 pmRNSHolding(s) in Company
17th Jun 20207:00 amRNSClosed period trading update
1st Jun 202010:33 amRNSTotal Voting Rights
29th May 202012:09 pmRNSHolding(s) in Company
28th May 20202:30 pmRNSDirectorate Change
28th May 202010:01 amRNSHolding(s) in Company
22nd May 20203:58 pmRNSDirector Declaration
14th May 20203:30 pmRNSDirector/PDMR Shareholding
14th May 20201:18 pmRNSResult of AGM
7th May 202011:00 amRNSDirector/PDMR Shareholding
1st May 202010:21 amRNSTotal Voting Rights
29th Apr 202012:55 pmRNSAmendment: AGM 2020 - Change of Arrangements
29th Apr 202011:30 amRNSDirector/PDMR Shareholding
29th Apr 202011:00 amRNSAGM 2020 - Change of Arrangements
28th Apr 202012:13 pmRNSDisclosure of rights attached to equity shares
21st Apr 20203:23 pmRNSDirector/PDMR Shareholding
15th Apr 20204:22 pmRNSDirector/PDMR Shareholding
9th Apr 20201:32 pmRNSDirector/PDMR Shareholding
2nd Apr 20207:00 amRNSTrading update regarding Coronavirus
1st Apr 202011:30 amRNSIssue of shares to Employee Share Ownership Trust
1st Apr 202010:21 amRNSTotal Voting Rights
27th Mar 202012:19 pmRNSHolding(s) in Company
19th Mar 20203:00 pmRNSNotice of AGM
12th Mar 20203:32 pmRNSAnnual Financial Report
9th Mar 20207:00 amRNSFiona Stanley Hospital £370m extension signed
5th Mar 20209:46 amRNSHolding(s) in Company
2nd Mar 202010:16 amRNSTotal Voting Rights
28th Feb 20207:00 amRNSDividend Declaration
26th Feb 20207:00 amRNSFinal Results
20th Feb 202010:24 amRNSGatwick Immigration Removal Centres £200m contract
7th Feb 202010:19 amRNSHolding(s) in Company
3rd Feb 202010:18 amRNSTotal Voting Rights
23rd Jan 20209:30 amRNSDirector Declaration
2nd Jan 202010:00 amRNSTotal Voting Rights
18th Dec 201912:02 pmRNSHolding(s) in Company
17th Dec 201911:49 amRNSHolding(s) in Company
12th Dec 20197:00 amRNSClosed Period trading update
9th Dec 20194:15 pmRNSHolding(s) in Company
2nd Dec 201910:56 amRNSTotal Voting Rights
7th Nov 201911:22 amRNSDirector/PDMR Shareholding
7th Nov 201911:21 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.